Vimarsana
Biggest News Aggregation in the World

Page 21 - Query Get News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Query Get. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Query Get Today - Breaking & Trending Today

Representation of women very low in academic internal medicine - Vimarsana News

Representation of women very low in academic internal medicine

Women remain significantly underrepresented in academic internal medicine leadership positions in the United States, according to findings published in the Journal of General Internal Medicine.Underrepresentation persisted despite a record-high percentage — 50.7% — of female medical students matriculating in 2017.

Source: healio.com
ED visits for seizures, epilepsy decreased during pandemic, especially in young children - Vimarsana News

ED visits for seizures, epilepsy decreased during pandemic, especially in young children

Seizure- and epilepsy-related emergency department visits decreased during the COVID-19 pandemic compared with pre-pandemic levels, with the largest drop seen among young children, per a study in MMWR. “Seizures generally account for approximately 1% of all emergency department visits,” Sanjeeb Sapkota, MBBS, MPH, of the Center for Global Health at the CDC, and colleagues wrote.

Source: healio.com
Q&A: Identifying, treating rare mucosal melanoma - Vimarsana News

Q&A: Identifying, treating rare mucosal melanoma

Mucosal melanoma — or melanoma in the mucous membranes — differs from cutaneous melanoma in its genesis, its treatment and its severity. Sometimes called a “hidden cancer,” mucosal melanoma is often more deadly than cutaneous melanoma. It is difficult to diagnose and often not found until the later stages, making treatment and survival more difficult.

Source: healio.com
CorneaGen recalls corneal, scleral patch grafts - Vimarsana News

CorneaGen recalls corneal, scleral patch grafts

CorneaGen issued product recalls for certain corneal and scleral patch grafts, according to press releases from the FDA.

Source: healio.com
FDA approves inhaled treprostinil for treatment of PAH, pulmonary hypertension-ILD - Vimarsana News

FDA approves inhaled treprostinil for treatment of PAH, pulmonary hypertension-ILD

United Therapeutics Corp. announced that the FDA has approved the Tyvaso dry powder inhaler for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease to improve exercise ability.Tyvaso DPI represents a new formulation and inhalation device for inhaled treprostinil and is the only dry powder inhaler approved by the FDA for use in PAH

Source: healio.com